Derek D. Satre

Derek D. Satre

Auto-generated profile, based on publicly available information

Derek D. Satre

Department of Psychiatry and Behavioral Sciences University of California, San Francisco San Francisco California USA

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2020 in The American Journal of Geriatric Psychiatry
Verified
Journal Article
Closed access
DSDerek D. Satre
Derek D. Satre
MHMatthew E. Hirschtritt
Matthew E. Hirschtritt
MSMichael J. Silverberg
Michael J. Silverberg
SSStacy A. Sterling
Stacy A. Sterling

11 June 2019 in Journal of General Internal Medicine
Verified
Journal Article
Closed access
PDF file
DSDerek D. Satre
Derek D. Satre
ALAmy S. Leibowitz
Amy S. Leibowitz
WLWendy Leyden
Wendy Leyden
SCSheryl L. Catz
Sheryl L. Catz
CHC. Bradley Hare
C. Bradley Hare
MSMichael J. Silverberg
Michael J. Silverberg

15 October 2021 in American Journal of Health Promotion
Verified
Journal Article
Closed access
PDF file
DSDerek D. Satre
Derek D. Satre
MMMeredith C. Meacham
Meredith C. Meacham
LALauren D. Asarnow
Lauren D. Asarnow
WFWeston S. Fisher
Weston S. Fisher
LFLisa R. Fortuna
Lisa R. Fortuna
EIEsti Iturralde
Esti Iturralde
The COVID-19 pandemic has heightened concerns about the impact of depression, anxiety, alcohol, and drug use on public health. Mobile apps to address these problems were increasingly popular even before the pandemic, and may help reach people who otherwise have limited treatment access. In this review, we describe pandemic-related substance use and mental health problems, the growing evidence for mobile app efficacy, how health systems can integrate apps into patient care, and future research directions. If equity in access and effective implementation can be addressed, mobile apps are likely to play an important role in mental health and substance use disorder treatment.

8 January 2021 in Drug and Alcohol Dependence
Verified
Journal Article
Closed access
DSDerek D. Satre
Derek D. Satre
TLTory Levine-Hall
Tory Levine-Hall
SSStacy A. Sterling
Stacy A. Sterling
KYKelly C. Young-Wolff
Kelly C. Young-Wolff
JLJennifer O. Lam
Jennifer O. Lam
MSMichael J. Silverberg
Michael J. Silverberg

1 February 2024 in Hepatology Communications
Verified
Journal Article
Open access
JLJeremy W. Luk
Jeremy W. Luk
DSDerek D. Satre
Derek D. Satre
RCRamsey Cheung
Ramsey Cheung
RWRobert Wong
Robert Wong
AMAlexander Monto
Alexander Monto
MKMandana Khalili
Mandana Khalili
Background: Management of cirrhosis is challenging and has been complicated by the COVID-19 pandemic due to decreased access to care, increased psychological distress, and alcohol misuse. Recently, The National Institute on Alcohol Abuse and Alcoholism has broadened the definition of recovery from alcohol use disorder to include quality of life (QoL) as an indicator of recovery. This study examined the associations of alcohol-associated cirrhosis etiology and problematic drinking with liver disease QoL (LDQoL). Methods: Patients with cirrhosis (N=329) were recruited from 3 sites (63% from 2 Veterans Affairs Health Care Systems and 37% from 1 safety net hospital) serving populations that are economically or socially marginalized. Cirrhosis etiology was ascertained by chart review of medical records. Problematic drinking was defined by ≥8 on the Alcohol Use Disorders Identification Test. Multivariable general linear modeling adjusting for age, sex, race/ethnicity, site, pandemic-related stress, and history of anxiety/depressive disorder were conducted. Sensitivity analyses further adjusted for indicators of liver disease severity. Results: Participants were on average 64.6 years old, 17% female, 58% non-White, 44% with alcohol-associated cirrhosis, and 17% with problematic drinking. Problematic drinking was significantly associated with worse LDQoL scores in the overall scale and in the memory/concentration and health distress subscales. These associations remained significant after adjusting for indicators of liver disease severity, including Model for End-Stage Liver Disease-Sodium score and decompensated cirrhosis status. Conclusions: Among patients with cirrhosis, problematic drinking was associated with worse LDQoL, especially in the domains of memory/concentration and health distress. Assessment and awareness of cognitive deficits and negative emotionality within the context of cirrhosis and problematic drinking may help clinicians provide better integrated care for this population. Export

1 September 2019 in Contemporary Clinical Trials
Verified
Journal Article
Closed access
DSDerek D. Satre
Derek D. Satre
AAAlexandra N. Anderson
Alexandra N. Anderson
ALAmy S. Leibowitz
Amy S. Leibowitz
TLTory Levine-Hall
Tory Levine-Hall
SSSally Slome
Sally Slome
MSMichael J. Silverberg
Michael J. Silverberg